- Home
- VERA vs BEATW Comparison
VERA vs BEATW Comparison
Compare VERA & BEATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- BEATW
- Stock Information
- Founded
- VERA 2016
- BEATW 2015
- Country
- VERA United States
- BEATW United States
- Employees
- VERA N/A
- BEATW 20
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- BEATW Retail: Computer Software & Peripheral Equipment
- Sector
- VERA Health Care
- BEATW Technology
- Exchange
- VERA Nasdaq
- BEATW Nasdaq
- Market Cap
- VERA N/A
- BEATW N/A
- IPO Year
- VERA 2021
- BEATW N/A
- Fundamental
- Price
- VERA $24.02
- BEATW $0.51
- Analyst Decision
- VERA Buy
- BEATW
- Analyst Count
- VERA 8
- BEATW 0
- Target Price
- VERA $65.50
- BEATW N/A
- AVG Volume (30 Days)
- VERA 680.0K
- BEATW 4.7K
- Earning Date
- VERA 05-08-2025
- BEATW 03-14-2025
- Dividend Yield
- VERA N/A
- BEATW N/A
- EPS Growth
- VERA N/A
- BEATW N/A
- EPS
- VERA N/A
- BEATW N/A
- Revenue
- VERA N/A
- BEATW N/A
- Revenue This Year
- VERA N/A
- BEATW N/A
- Revenue Next Year
- VERA N/A
- BEATW N/A
- P/E Ratio
- VERA N/A
- BEATW N/A
- Revenue Growth
- VERA N/A
- BEATW N/A
- 52 Week Low
- VERA $22.34
- BEATW $0.50
- 52 Week High
- VERA $51.61
- BEATW $0.62
- Technical
- Relative Strength Index (RSI)
- VERA 27.81
- BEATW N/A
- Support Level
- VERA $25.55
- BEATW N/A
- Resistance Level
- VERA $26.89
- BEATW N/A
- Average True Range (ATR)
- VERA 1.22
- BEATW 0.00
- MACD
- VERA -0.03
- BEATW 0.00
- Stochastic Oscillator
- VERA 23.80
- BEATW 0.00
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.